Reata Pharmaceuticals Inc (RETA) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Reata Pharmaceuticals Inc   (NASDAQ: RETA)


Reata Pharmaceuticals Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Reata Pharmaceuticals Inc's ROI in the second quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Reata Pharmaceuticals Inc 's return on investment (ROI) in its second quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM - - -88.13 % -71.8 % -61.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 160 -131 -66 5 69
Return On Investment (TTM) 1115.12 % - - -322.31 % -189.44 %
RETA's Overall Ranking # # # # #
Seq. Investment Change TTM - - -65.05 % -39.84 % -27.99 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -88 -354 -312 -312 -305

RETA Company Profile >> Back to RETA Roi Comparisons >> See Annual RETA Return On Investment



Return On Investment RETA's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Reata Pharmaceuticals Inc's II. Quarter Investments $ 160 Millions RETA's Balance sheet
Reata Pharmaceuticals Inc's II. Quarter Income $ 193 Millions Quarterly RETA's Income Statement
RETA's Income by Division See RETA's Income by Division


RETA Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -66 186 418 490 95
Y / Y Investment Growth - -55.51 % -14.75 % 416.75 % 8.19 %
Net Income in Millions -312 -297 -248 -290 -81
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -159.89 % -59.26 % -59.17 % -84.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RETA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RETA's Competitors
Subscribers only: Roi for Reata Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for RETA's Customers

Other Ratios
RETA's Roa RETA's Inventory Turnover Ratio RETA's Growth Rates RETA's Dividend Statistics
RETA's Profitability Ratios RETA's Asset Turnover Ratio RETA's Dividend Growth
RETA's Roe RETA's Valuation Ratios RETA's Financial Strength Ratios RETA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Therapeuticsmd Inc   226.36 %

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.